ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.33
1.50%
US Tech 100
19,167.20
2.31%
S&P 500
5,638.94
2.13%
US Dollar vs CAD
1.43875
0.00%
Bitcoin
83,951.52
-0.01%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Larimar Therapeutics Inc (LRMR) Share Price

Larimar Therapeutics Inc

Larimar Therapeutics Inc (LRMR)

NASDAQ
2.59
-0.02
(-0.77%)
Closed March 15 3:00PM
Delayed by 15 minutes
2.59
0.00
(0.00%)
After Hours: 4:58PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.59
Bid
2.59
Ask
2.68
Volume
486,215
2.565 Day's Range 2.70
2.522 52 Week Range 11.20
Market Cap
165.259M
Previous Close
2.61
Open
2.65
Last Trade
13
@
2.59
Last Trade Time
Financial Volume
US$ 1,270,597
VWAP
2.6132
Average Volume (3m)
596,123
Shares Outstanding
63,806,628
Dividend Yield
-
PE Ratio
-1.71
Earnings Per Share (EPS)
-0.58
Revenue
-
Net Profit
-36.95M

About Larimar Therapeutics Inc

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion p... Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
larimartx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Larimar Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LRMR. The last closing price for Larimar Therapeutics was US$2.61. Over the last year, Larimar Therapeutics shares have traded in a share price range of US$ 2.522 to US$ 11.20.

Larimar Therapeutics currently has 63,806,628 shares outstanding. The market capitalization of Larimar Therapeutics is US$166.54 million. Larimar Therapeutics has a price to earnings ratio (PE ratio) of -1.71.

Ask ADVFN Intelligence (AI)

LRMR Latest News

More News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
February 04 2025
LRMR (-0.77%)

Form 8-K - Current report
Edgar (US Regulatory)
January 27 2025
LRMR (-0.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 24 2025
LRMR (-0.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 24 2025
LRMR (-0.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 24 2025
LRMR (-0.77%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 24 2025
LRMR (-0.77%)

Form 8-K - Current report
Edgar (US Regulatory)
January 10 2025
LRMR (-0.77%)

Form 8-K - Current report
Edgar (US Regulatory)
December 16 2024
LRMR (-0.77%)

Form 8-K - Current report
Edgar (US Regulatory)
November 18 2024
LRMR (-0.77%)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Edgar (US Regulatory)
November 14 2024
LRMR (-0.77%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.46-15.08196721313.053.192.54176877262.70744694CS
4-0.71-21.51515151523.33.522.5225429972.94145127CS
12-1.36-34.43037974683.954.272.5225961233.45942345CS
26-4.61-64.02777777787.29.52.5227498835.49255862CS
52-6.47-71.4128035329.0611.22.5226052056.51746743CS
156-1.34-34.0966921123.9313.681.533479096.05838264CS
260-9.41-78.41666666671225.871.532541226.69206478CS

LRMR - Frequently Asked Questions (FAQ)

What is the current Larimar Therapeutics share price?
The current share price of Larimar Therapeutics is US$ 2.59
How many Larimar Therapeutics shares are in issue?
Larimar Therapeutics has 63,806,628 shares in issue
What is the market cap of Larimar Therapeutics?
The market capitalisation of Larimar Therapeutics is USD 166.54M
What is the 1 year trading range for Larimar Therapeutics share price?
Larimar Therapeutics has traded in the range of US$ 2.522 to US$ 11.20 during the past year
What is the PE ratio of Larimar Therapeutics?
The price to earnings ratio of Larimar Therapeutics is -1.71
What is the reporting currency for Larimar Therapeutics?
Larimar Therapeutics reports financial results in USD
What is the latest annual profit for Larimar Therapeutics?
The latest annual profit of Larimar Therapeutics is USD -36.95M
What is the registered address of Larimar Therapeutics?
The registered address for Larimar Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Larimar Therapeutics website address?
The website address for Larimar Therapeutics is larimartx.com
Which industry sector does Larimar Therapeutics operate in?
Larimar Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RDUSRadius Recycling Inc
US$ 27.902
(104.26%)
8.53M
BONBon Natural Life Ltd
US$ 1.40
(90.29%)
84M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 255.00
(39.80%)
222
AAOIApplied Optoelectronics Inc
US$ 22.105
(39.29%)
17.01M
GLSTUGlobal Star Acquisition Inc
US$ 2.00
(-69.23%)
421
CURRCurrenc Group Inc
US$ 2.03
(-41.33%)
1.42M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
WKSPWorksport Ltd
US$ 0.36205
(-35.45%)
4.96M
SUNESUNation Energy Inc
US$ 0.5213
(62.96%)
513.96M
NVDANVIDIA Corporation
US$ 121.67
(5.27%)
277.56M
ADTXAditxt Inc
US$ 0.0201
(-39.82%)
240.2M
HEPAHepion Pharmaceuticals Inc
US$ 0.0228
(-39.68%)
161.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9.225
(7.64%)
160.21M

LRMR Discussion

View Posts
tw0122 tw0122 8 months ago
LRMR above $9 momentarily
👍️0
Monksdream Monksdream 11 months ago
LRMR under $10

👍️0
Monksdream Monksdream 11 months ago
LRMR under $10
👍️0
Monksdream Monksdream 1 year ago
LRMR new 52 week high
👍️0
Monksdream Monksdream 1 year ago
LRMR new 52=week high
👍️0
AJ Freely AJ Freely 2 years ago
$LRMR - Announced that the FDA has cleared the Company’s four-week, placebo-controlled, Phase 2 dose exploration trial of CTI-1601
👆Up 8% Pre-Market/ Current Price $3,40
👍️0
magacrew2020 magacrew2020 2 years ago
could probably get through approval on just 25 mg if they are going to approve reta
👍️0
subslover subslover 3 years ago
The company said it received feedback from the FDA on information needed to resolve CTI-1601's current clinical hold, as well as a proposed change for a second phase. CTI-1601 is a treatment for Friedreich's ataxia.

Larimer plans to submit a complete response to CTI-1601's clinical hold in the third quarter.

Larimar is also proposing a phase two, four-week dose exploration study in Friedreich's ataxia patients. Friedreich's ataxia is a rare disease that causes progressive nervous system damage and movement problems, usually beginning during childhood.
👍️0
JJJ54 JJJ54 3 years ago
I voted NO on the 2022 Annual Meeting Vote. I recommend you do the same.
👍️0
DarkPool DarkPool 3 years ago
Interesting.
👍️0
oxnous oxnous 4 years ago
Waking up . But volume should be higher.
👍️0
DewDiligence DewDiligence 5 years ago
LRMR 2Q20 results—6/30/20 cash=$113.7M:

https://www.globenewswire.com/news-release/2020/08/11/2076240/0/en/Larimar-Therapeutics-Reports-Second-Quarter-2020-Operating-and-Financial-Results.html

No CC.
👍️0
casenumber casenumber 5 years ago
Large chunks are being gobbled
Whales are lurking around?
👍️0
subslover subslover 5 years ago
The company they are merging with looks pretty darn impressive
https://chondrialtherapeutics.com/
👍️0
casenumber casenumber 5 years ago
Volume!
👍️0
ClayTrader ClayTrader 5 years ago
* * $ZFGN Video Chart 12-26-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 years ago
* * $ZFGN Video Chart 12-24-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
whytestocks whytestocks 5 years ago
News: $ZFGN Penny Stocks To Buy Or Sell Before The End Of 2019?

These Penny Stocks Moved Big But Can They Continue Higher Before Next Year? Over the course of the year, plenty of penny stocks have generated significant gains for investors. Even as the year comes to a close, there are some penny stocks that are gaining momentum. It is often said that inve...

Got this from ZFGN - Penny Stocks To Buy Or Sell Before The End Of 2019?
👍️0
Fat Thor Fat Thor 5 years ago
Like I said at .67 cents
👍️0
ClayTrader ClayTrader 5 years ago
* * $ZFGN Video Chart 12-23-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
casenumber casenumber 5 years ago
Wow...guess they will satisfy the 1dollar minimum nasd requirement with out rs.....
This will be huge when ticker change and merger consummated next month!

Scrap the notice of delisting boys.....

82M cash and 30M OS....sounds fun!
👍️0
ClayTrader ClayTrader 5 years ago
* * $ZFGN Video Chart 12-20-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
casenumber casenumber 5 years ago
Over a buck soon when ticker change completed....
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
exactly is great
👍️0
Fat Thor Fat Thor 5 years ago
Probably 3-9 months away still - appears to be a massive over correction and tax loss selling on the merger news. Just a short target at the moment. They will run this in Q1 pre-split to get a much more favorable ratio IMO. Let's see what happens. Lots of cash on hand here at very low burn rate per Q.

The transaction is expected to close in the first half of 2020, subject to approvals by stockholders of each company and other customary closing conditions.
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
R/Split coming per 8k today
👍️0
Fat Thor Fat Thor 5 years ago
December discounts. With 85 million in cash, a merger, and priced at 67 cents there's no way this doesn't run soon. 35 million O/S.
👍️0
casenumber casenumber 5 years ago
Ticker change coming...Shorts will get burn if they will not cover or do damage control.
ZFGN has 82M dollars in cash!

The proposed merger will result in a combined publicly traded, clinical-stage biopharmaceutical company operating under a new name, Larimar Therapeutics, Inc.
👍️0
casenumber casenumber 5 years ago
Shorts covering.. they have to before it gets out of control once the merger is official...
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
10 day MA live chart huge oversold,safe here now,will recover nice
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
bought 3k at 6391
👍️0
Fat Thor Fat Thor 5 years ago
Just saw a bunch come through on tape that were vastly different but didn't indicate "out of sequence"...they were either out of sequence or it was a messed up market order. Just odd. This one is clearly under short attack. Volume could squeeze it near term.
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
ZFGN~~Balance Sheet
Total Cash (mrq) 82.01M
Total Cash Per Share (mrq) 2.19
Total Debt (mrq) 24.35M
Total Debt/Equity (mrq) 40.67
Current Ratio (mrq) 5.11
Book Value Per Share (mrq) 1.60
https://finance.yahoo.com/quote/ZFGN/key-statistics?p=ZFGN



👍️0
alchemytrader alchemytrader 5 years ago
not really. that would mean its been up and down, up and down. this is nothing but down..
👍️0
Fat Thor Fat Thor 5 years ago
...this price action is ALL over the place. Crazy.
👍️0
alchemytrader alchemytrader 5 years ago
man i hope so. just want out even now
👍️0
BoilerRoom BoilerRoom 5 years ago
$ZFGN in at .70
👍️0
BoilerRoom BoilerRoom 5 years ago
Short this
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
will recover but sucks,waste of time
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
Zafgen and Chondrial Therapeutics will host an investor conference call today, December 18, 2019, at 8:30 a.m.,
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
Conference Call Information
Zafgen and Chondrial Therapeutics will host an investor conference call today, December 18, 2019, at 8:30 a.m., Eastern Time, to discuss the merger as well as other forward-looking information. Investors and other interested parties may participate by dialing (844) 824-7428 in the United States or (973) 500-2177 outside the United States and referencing conference ID number 5688136. The call will also be webcast live on the Company's website at https://zafgen.gcs-web.com/events-and-presentations. A replay of this conference call will be available beginning at 11:30 a.m. ET on December 18, 2019 through December 25, 2019 by dialing (855) 859-2056 in the United States or (404) 537-3406 outside the United States. To access the replay please provide Conference ID number 5688136.
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
dont think so
👍️0
Widowsson32 Widowsson32 5 years ago
This is done no benefit to this company but ONTX will make you very rich
👍️0
alchemytrader alchemytrader 5 years ago
institutions selling off?
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
the news is great,why?
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
fffffffffffffffffff MMS
👍️0
alchemytrader alchemytrader 5 years ago
i guess were screwed
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
f MMs
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
.79 f
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 years ago
what the heck is going on here?
👍️0

Your Recent History

NASDAQ
LRMR
Larimar Therapeutics
LSE
0OEA
Dupnitsa Tabak Ad Dupnitsa
NASDAQ
CDYAX
Ci Global Investment Gra...
COIN
CMITEUR
CMITCOIN
LSE
PT82
Rep Ghana 30s
LSE
82MX
Arran Res Dbs
LSE
0NQ3
Mr Bricolage
NYSE
APCA
AP Acquisition
NASDAQ
FCUV
Focus Universal
BIT
AL8641
Banca Aletti and C
BIT
P1SSG2
BNP Paribas Issuance
TSXV
TIN.H
Eurotin
BIT
F28930
Vontobel Financial Produ...
LSE
APU
USOTC
CRTG
Coretec (CE)
BIT
UC4WFG
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads